HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection

被引:7
作者
Khurana, Surender [1 ]
Norris, Philip J. [2 ,3 ]
Busch, Michael P. [2 ,3 ]
Haynes, Barton F. [4 ]
Park, Susan [1 ]
Sasono, Pretty [1 ]
Mlisana, Koleka [5 ]
Salim, Abdool Karim [5 ]
Hecht, Frederick M. [3 ]
Mulenga, Joseph [6 ,7 ]
Chomba, Elwyn [7 ]
Hunter, Eric [8 ]
Allen, Susan [9 ]
Nemo, George [10 ]
Rodriguez-Chavez, Isaac R. [11 ]
Margolick, Joseph B. [13 ]
Golding, Hana [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD 20892 USA
[2] Blood Syst Res Inst, San Francisco, CA 94118 USA
[3] Univ Calif San Francisco, San Francisco, CA 94118 USA
[4] Duke Human Vaccine Inst, Durham, NC 27710 USA
[5] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Durban, South Africa
[6] ZEHRP, Lusaka, Zambia
[7] Zambia Blood Transfus Serv, Lusaka, Zambia
[8] Emory Vaccine Res Ctr, Atlanta, GA 30329 USA
[9] Emory Univ, Sch Publ Hlth, Atlanta, GA 30322 USA
[10] NHLBI, NIH, Bethesda, MD 20817 USA
[11] Natl Inst Dent & Craniofacial Res, AIDS & Immunosuppress Program, NIH, Bethesda, MD 20892 USA
[12] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[13] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
基金
新加坡国家研究基金会;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; VACCINE-GENERATED ANTIBODIES; DIFFERENTIAL-DIAGNOSIS; ANTIRETROVIRAL THERAPY; RNA LEVELS; PLASMA; RESPONSES; VIREMIA; FACE;
D O I
10.1128/JCM.01573-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 11 条
[1]   Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection [J].
Fiebig, EW ;
Wright, DJ ;
Rawal, BD ;
Garrett, PE ;
Schumacher, RT ;
Peddada, L ;
Heldebrant, C ;
Smith, R ;
Conrad, A ;
Kleinman, SH ;
Busch, MP .
AIDS, 2003, 17 (13) :1871-1879
[2]   Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection [J].
Gray, E. S. ;
Moore, P. L. ;
Choge, I. A. ;
Decker, J. M. ;
Bibollet-Ruche, F. ;
Li, H. ;
Leseka, N. ;
Treurnicht, F. ;
Mlisana, K. ;
Sha, G. M. ;
Karim, S. S. Abdool ;
Williamson, C. ;
Morris, L. .
JOURNAL OF VIROLOGY, 2007, 81 (12) :6187-6196
[3]   Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 [J].
Haaland, Richard E. ;
Hawkins, Paulina A. ;
Salazar-Gonzalez, Jesus ;
Johnson, Amber ;
Tichacek, Amanda ;
Karita, Etienne ;
Manigart, Olivier ;
Mulenga, Joseph ;
Keele, Brandon F. ;
Shaw, George M. ;
Hahn, Beatrice H. ;
Allen, Susan A. ;
Derdeyn, Cynthia A. ;
Hunter, Eric .
PLOS PATHOGENS, 2009, 5 (01)
[4]   Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies [J].
Khurana, S ;
Needham, J ;
Mathieson, B ;
Rodriguez-Chavez, IR ;
Catanzaro, AT ;
Bailer, RT ;
Kim, J ;
Polonis, V ;
Cooper, DA ;
Guerin, J ;
Peterson, ML ;
Gurwith, M ;
Nguyen, N ;
Graham, BS ;
Golding, H .
JOURNAL OF VIROLOGY, 2006, 80 (05) :2092-2099
[5]   Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: Utility for detection of diverse HIV-1 subtypes [J].
Khurana, Surender ;
Needham, James ;
Park, Susan ;
Mathieson, Bonnie ;
Busch, Michael P. ;
Nemo, George ;
Nyambi, Phillipe ;
Zolla-Pazner, Susan ;
Laal, Suman ;
Mulenga, Joseph ;
Chomba, Elwyn ;
Hunter, Eric ;
Allen, Susan ;
McIntyre, James ;
Hewlett, Indira ;
Lee, Sherwin ;
Tang, Shixing ;
Cowan, Elliot ;
Beyrer, Chris ;
Altfeld, Marcus ;
Yu, Xu G. ;
Tounkara, Anatole ;
Koita, Ousmane ;
Kamali, Anatoli ;
Nguyen, Nga ;
Graham, Barney S. ;
Todd, Deborah ;
Mugenyi, Peter ;
Anzala, Omu ;
Sanders, Eduard ;
Ketter, Nzeera ;
Fast, Patricia ;
Golding, Hana .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (03) :304-312
[6]  
McKenna SL, 1997, AIDS, V11, pS103
[7]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[8]   Gender difference in HIV RNA levels: A meta-analysis of published studies [J].
Napravnik, S ;
Poole, C ;
Thomas, JC ;
Eron, JJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (01) :11-19
[9]   Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia [J].
Tomaras, Georgia D. ;
Yates, Nicole L. ;
Liu, Pinghuang ;
Qin, Li ;
Fouda, Genevieve G. ;
Chavez, Leslie L. ;
Decamp, Allan C. ;
Parks, Robert J. ;
Ashley, Vicki C. ;
Lucas, Judith T. ;
Cohen, Myron ;
Eron, Joseph ;
Hicks, Charles B. ;
Liao, Hua-Xin ;
Self, Steven G. ;
Landucci, Gary ;
Forthal, Donald N. ;
Weinhold, Kent J. ;
Keele, Brandon F. ;
Hahn, Beatrice H. ;
Greenberg, Michael L. ;
Morris, Lynn ;
Karim, Salim S. Abdool ;
Blattner, William A. ;
Montefiori, David C. ;
Shaw, George M. ;
Perelson, Alan S. ;
Haynes, Barton F. .
JOURNAL OF VIROLOGY, 2008, 82 (24) :12449-12463
[10]   Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates [J].
Touloumi, G ;
Pantazis, N ;
Babiker, AG ;
Walker, SA ;
Katsarou, O ;
Karafoulidou, A ;
Hatzakis, A ;
Porter, K .
AIDS, 2004, 18 (12) :1697-1705